Pancreatic cancer is usually found through imaging tests after symptoms appear, not through screening

Pancreatic cancer is rarely caught early because the pancreas sits deep in the abdomen and early tumors cause no symptoms. Most people are diagnosed after they develop jaundice (yellowing of skin and eyes), abdominal pain, or unexplained weight loss—and by then the cancer has often spread. The diagnosis itself involves imaging to locate the tumor, blood tests to measure tumor markers, and usually a biopsy to confirm cancer cells are present.

Unlike breast or colon cancer, there is no routine screening test for pancreatic cancer in people without symptoms or known risk factors. Diagnosis begins when a doctor orders imaging—usually a CT scan or MRI—because of symptoms or findings on an earlier test. If imaging shows a suspicious mass, the next step is almost always a biopsy to confirm it is cancer and determine what type.

Key Takeaways

  • Pancreatic cancer diagnosis starts with imaging tests (CT or MRI) ordered because of symptoms like jaundice, pain, or weight loss, not through screening.
  • A biopsy—taking a tissue sample through a needle or during surgery—is needed to confirm cancer and identify the specific type.
  • Blood tests measure CA 19-9, a tumor marker that can support diagnosis but is not specific enough to diagnose pancreatic cancer alone.
  • Once cancer is confirmed, additional tests (staging scans, genetic testing) determine how far it has spread and guide treatment decisions.

The imaging tests that locate a pancreatic tumor

A CT scan (computed tomography) is the most common first imaging test. It takes detailed cross-section images of the abdomen and can show a tumor in the pancreas, whether it has spread to nearby organs, and whether blood vessels are involved. The scan takes 10 to 15 minutes and uses X-rays, so you receive a small dose of radiation.

An MRI (magnetic resonance imaging) uses magnetic fields instead of radiation and can show soft tissue detail that CT sometimes misses. It is often ordered if CT results are unclear or if the doctor wants to look closely at the bile ducts (tubes that carry digestive fluid). MRI takes longer than CT—usually 30 to 45 minutes—and is noisier, but it does not use radiation.

Endoscopic ultrasound (EUS) is a procedure where a thin tube with an ultrasound probe is passed down your throat and into the small intestine, allowing the doctor to get close-up images of the pancreas. EUS can also be used to take a biopsy sample. It requires sedation and takes 20 to 30 minutes.

How a biopsy confirms pancreatic cancer

A biopsy is the only way to confirm that a pancreatic mass is cancer. The doctor removes a small sample of tissue and a pathologist examines it under a microscope to look for cancer cells. There are several ways to obtain this sample.

Endoscopic ultrasound-guided biopsy (EUS-FNA) is often the first choice. During EUS, the doctor uses ultrasound to guide a thin needle through the stomach wall into the pancreatic mass and withdraws cells or tissue. This is done while you are sedated and takes 20 to 30 minutes. Results come back in a few days to a week.

CT-guided biopsy uses CT imaging to guide a needle through the skin into the tumor. You lie still on the CT table while the radiologist advances the needle and takes samples. This is also done with local anesthesia and takes 15 to 30 minutes. It is often used when the tumor is in the tail of the pancreas or when EUS is not possible.

Surgical biopsy removes tissue during an operation. This may happen if the surgeon is already operating to remove the tumor, or if other biopsy methods have not given a clear answer. A surgical biopsy gives the most tissue but requires general anesthesia and recovery time.

Blood tests that support diagnosis

A blood test measuring CA 19-9 is often ordered when pancreatic cancer is suspected. CA 19-9 is a protein that pancreatic cancer cells often produce in high amounts. An elevated level can support a diagnosis of pancreatic cancer, but it is not specific—some benign pancreatic conditions and other cancers can also raise CA 19-9, and some pancreatic cancers do not raise it at all.

CA 19-9 is more useful after diagnosis than before it. Once cancer is confirmed, the baseline CA 19-9 level helps doctors track whether treatment is working. If the level drops after surgery or chemotherapy, that is a good sign. If it rises, it may mean the cancer is returning or not responding to treatment.

Other blood tests check liver function and measure bilirubin (the pigment that causes jaundice). These tests do not diagnose cancer but show whether the tumor is blocking bile ducts or affecting the liver, which influences treatment planning.

Staging tests that show how far cancer has spread

Once pancreatic cancer is confirmed by biopsy, the doctor orders additional imaging to determine the stage—how large the tumor is and whether it has spread to lymph nodes, distant organs, or blood vessels. This staging guides treatment decisions and prognosis.

Staging CT or MRI of the chest, abdomen, and pelvis looks for spread to the lungs, liver, peritoneum (the lining of the abdominal cavity), and other organs. PET-CT (positron emission tomography combined with CT) can detect cancer cells in distant sites that standard imaging might miss, though it is not always ordered for pancreatic cancer.

The doctor may also order laparoscopy—a minimally invasive procedure where a thin camera is inserted through a small cut in the abdomen to look directly at organs and take biopsies of suspicious areas. This can reveal spread that imaging missed and sometimes changes treatment plans.

Genetic testing and molecular profiling

After diagnosis, the tumor tissue from the biopsy is often tested for specific genetic mutations. Some pancreatic cancers have mutations in genes like BRCA1, BRCA2, PALB2, or KRAS. Knowing which mutations are present can guide chemotherapy choices and may open access to targeted drugs or clinical trials.

If you have a family history of pancreatic cancer or certain other cancers, your doctor may recommend genetic testing of your own blood to see whether you carry an inherited mutation that increases cancer risk. This information matters for your relatives and for your own follow-up care.

What happens after diagnosis is confirmed

Once pancreatic cancer is confirmed and staged, your doctor will discuss treatment options. These depend on the stage, your overall health, and whether the tumor can be surgically removed. Treatment may include surgery, chemotherapy, radiation, or a combination. Some people are also offered clinical trials testing newer approaches.

You will likely meet with a team that includes a surgical oncologist, medical oncologist, and sometimes a radiation oncologist. They will review your imaging and biopsy results together and recommend a treatment plan tailored to your situation.

Frequently Asked Questions

Can pancreatic cancer be found before symptoms start?

Not routinely. There is no screening test for people without symptoms or known risk factors. People with a strong family history of pancreatic cancer or inherited mutations may be offered surveillance with MRI or EUS, but this is uncommon. Most pancreatic cancers are found after symptoms appear.

How long does it take to get a diagnosis?

From first imaging to confirmed diagnosis usually takes two to four weeks. The CT or MRI can be scheduled within days. The biopsy may happen during that same imaging procedure or a few days later. Pathology results typically come back within a week of the biopsy.

Is a biopsy always necessary?

In most cases, yes. A biopsy is the only way to confirm cancer and determine the specific type. Occasionally, if imaging shows a very typical pancreatic cancer appearance and CA 19-9 is very high, a doctor may proceed with treatment without a biopsy, but this is rare.

What does it mean if CA 19-9 is normal?

A normal CA 19-9 does not rule out pancreatic cancer. About 10 to 15 percent of pancreatic cancers do not produce elevated CA 19-9. Diagnosis depends on biopsy findings, not on this blood test alone.

Will I need more imaging after diagnosis?

Yes. After the initial biopsy confirms cancer, staging scans (CT, MRI, or PET-CT) are ordered to see whether the cancer has spread. These results determine whether surgery is possible and what chemotherapy or radiation might be recommended.